Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation

Department of Hepatobiliary Surgery and Liver Transplantation, Liver Cancer Institute, Zhongshan Hospital Fudan University; Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education Shanghai China

G

Gang Wang

M

Mengmeng Jiang

B

Bing Li

Genentech, Inc., Department of Protein Engineering, 460 Point San Bruno Boulevard, South San Francisco, CA 94080

Celera Genomics, 45 West Gude Drive, Rockville, MD 20850, USA.

J

Jian Liu

Department of Chemistry, Yale University, New Haven, Connecticut 06520, United States

Cite This Article

Ren Guo, Xiaohui Jia, Zhenbin Ding, et al. (2022). Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation. Theranostics, 12(11), 5220-5236. https://doi.org/10.7150/thno.71400

Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation

You May Also Like